The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The Breast Cancer Weight Loss (BWEL) trial: Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early-stage breast cancer (Alliance A011401).
 
Jennifer A. Ligibel
No Relationships to Disclose
 
William Thomas Barry
Research Funding - Pfizer (Inst)
Other Relationship - ARMO BioSciences
 
Catherine M. Alfano
No Relationships to Disclose
 
Dawn L. Hershman
No Relationships to Disclose
 
Melinda L Irwin
No Relationships to Disclose
 
Marian Neuhouser
No Relationships to Disclose
 
Cynthia A. Thomson
No Relationships to Disclose
 
Linda Delahanty
Consulting or Advisory Role - Omada Health
 
Elizabeth Frank
No Relationships to Disclose
 
Patricia Spears
Consulting or Advisory Role - Pfizer
Travel, Accommodations, Expenses - Roche/Genentech; Roche/Genentech
 
Electra D. Paskett
Stock and Other Ownership Interests - Meridian Bioscience Inc; Meridian Bioscience Inc (I); Pfizer; Pfizer (I)
Research Funding - Merck (Inst)
 
Judith O. Hopkins
Consulting or Advisory Role - AIM Specialty Health
 
Vanessa Bernstein
No Relationships to Disclose
 
Vered Stearns
Research Funding - Abbvie; MedImmune; Novartis; Pfizer; Puma Biotechnology
 
Julia R. White
Honoraria - Qfix
Research Funding - Intraop Medical (Inst)
Travel, Accommodations, Expenses - Qfix
 
Thomas Wadden
No Relationships to Disclose
 
Pamela Jean Goodwin
Consulting or Advisory Role - Novo Nordisk
 
Lisa A. Carey
Research Funding - Genentech/Roche (Inst); Innocrin Pharma (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Royalty-sharing agreement, investorship interest in licensed IP to startup company, Falcon Therapeutics, that is designing neural stem cell-based therapy for glioblastoma multiforme. (I)
 
Ann Partridge
No Relationships to Disclose
 
Eric P. Winer
No Relationships to Disclose